This symposium is the 6th meeting organized jointly between the Medicinal Chemistry Section of the Swedish Academy of Pharmaceutical Sciences and the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry, to showcase the very best medicinal chemistry in a stimulating environment. It is also designed to provide plenty of opportunities to meet other delegates, renew friendships and foster new contacts. Please circulate this information widely around your networks. Topics The following will be covered: Kinases, GPCRs, Enzymes, protein-protein interactions, epigenetics, chemical biology, emerging target classes, as well as new interesting technologies within the field. There will also be a poster session and we welcome abstracts for consideration.
For further details, see: www.lakemedelsakademin.se or email email@example.com
Dave Alker, David Alker Associates, UK Adrian Hall, Eisai Ltd, UK Carlos Garcia-Echeverria, Sanofi, France Charles Hedgecock, Meira Life Science AB, Sweden Kevin Dack, LEO Pharma, Denmark Ed J Griffen, AstraZeneca R&D, UK Thomas Hansson, AstraZeneca R&D, Sweden Lilian Walther Jallow, Swedish Academy of Pharmaceutical Sciences, Sweden